Barbara J. Schiemann

2.3k total citations · 1 hit paper
17 papers, 1.8k citations indexed

About

Barbara J. Schiemann is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Barbara J. Schiemann has authored 17 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Barbara J. Schiemann's work include Cancer Cells and Metastasis (7 papers), TGF-β signaling in diseases (6 papers) and Cell Adhesion Molecules Research (4 papers). Barbara J. Schiemann is often cited by papers focused on Cancer Cells and Metastasis (7 papers), TGF-β signaling in diseases (6 papers) and Cell Adhesion Molecules Research (4 papers). Barbara J. Schiemann collaborates with scholars based in United States, Taiwan and China. Barbara J. Schiemann's co-authors include William P. Schiemann, Kalpit A. Vora, Jennifer L. Gommerman, Martin Scott, Max Dobles, Teresa G. Cachero, Svetlana Shulga‐Morskaya, Michael K. Wendt, Jason R. Neil and Molly A. Taylor and has published in prestigious journals such as Science, Journal of Biological Chemistry and Oncogene.

In The Last Decade

Barbara J. Schiemann

17 papers receiving 1.8k citations

Hit Papers

An Essential Role for BAFF in the Normal Development of B... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara J. Schiemann United States 15 807 685 484 368 200 17 1.8k
Katsuhiko Nakashima Japan 18 571 0.7× 1.0k 1.5× 362 0.7× 430 1.2× 350 1.8× 24 1.9k
V Castronovo Belgium 27 658 0.8× 1.4k 2.0× 674 1.4× 308 0.8× 397 2.0× 38 2.3k
Vincent Castronovo Belgium 16 347 0.4× 780 1.1× 441 0.9× 201 0.5× 209 1.0× 20 1.3k
Stefania Canè Italy 23 768 1.0× 619 0.9× 698 1.4× 310 0.8× 70 0.3× 39 2.0k
Todd W. Kelley United States 26 622 0.8× 707 1.0× 325 0.7× 229 0.6× 142 0.7× 68 2.0k
Theodore J. Yun United States 15 723 0.9× 1.0k 1.5× 602 1.2× 216 0.6× 123 0.6× 22 1.7k
Osamu Hosono Japan 23 352 0.4× 491 0.7× 623 1.3× 239 0.6× 116 0.6× 70 1.4k
Irene Sizing United States 14 1.2k 1.5× 567 0.8× 270 0.6× 398 1.1× 192 1.0× 15 1.9k
E B Bröcker Germany 19 614 0.8× 653 1.0× 442 0.9× 197 0.5× 196 1.0× 27 1.5k
Valeria Visconte United States 29 756 0.9× 1.4k 2.0× 406 0.8× 426 1.2× 240 1.2× 181 3.2k

Countries citing papers authored by Barbara J. Schiemann

Since Specialization
Citations

This map shows the geographic impact of Barbara J. Schiemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara J. Schiemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara J. Schiemann more than expected).

Fields of papers citing papers by Barbara J. Schiemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara J. Schiemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara J. Schiemann. The network helps show where Barbara J. Schiemann may publish in the future.

Co-authorship network of co-authors of Barbara J. Schiemann

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara J. Schiemann. A scholar is included among the top collaborators of Barbara J. Schiemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara J. Schiemann. Barbara J. Schiemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Erokwu, Bernadette O., Barbara J. Schiemann, Chunying Wu, et al.. (2025). Dynamic contrast enhanced‐magnetic resonance fingerprinting (DCEMRF): A new quantitative MRI method to reliably assess tumor vascular perfusion. Magnetic Resonance in Medicine. 94(6). 2578–2592. 1 indexed citations
2.
Schiemann, Barbara J., et al.. (2020). SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness. Life Science Alliance. 3(4). e201900427–e201900427. 14 indexed citations
3.
Bledzka, Kamila, Barbara J. Schiemann, William P. Schiemann, et al.. (2017). The WAVE3-YB1 interaction regulates cancer stem cells activity in breast cancer. Oncotarget. 8(61). 104072–104089. 29 indexed citations
4.
Wendt, Michael K., Pete E. Pascuzzi, Nikolas G. Balanis, et al.. (2015). The Antitumorigenic Function of EGFR in Metastatic Breast Cancer is Regulated by Expression of Mig6. Neoplasia. 17(1). 124–133. 33 indexed citations
5.
Zhang, Yuan, Adriana Popa, Anna Cristina S. Samia, et al.. (2015). Detection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood Samples. PubMed. 5(2). 93–100. 14 indexed citations
6.
Wendt, Michael K., Molly A. Taylor, Barbara J. Schiemann, Khalid Sossey‐Alaoui, & William P. Schiemann. (2014). Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers. Breast Cancer Research. 16(2). R24–R24. 55 indexed citations
7.
Balanis, Nikolas G., Michael K. Wendt, Barbara J. Schiemann, et al.. (2013). Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway. Journal of Biological Chemistry. 288(25). 17954–17967. 115 indexed citations
8.
Parvani, Jenny G., Amy Galliher-Beckley, Barbara J. Schiemann, & William P. Schiemann. (2013). Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β. Molecular Biology of the Cell. 24(21). 3449–3459. 86 indexed citations
9.
Taylor, Molly A., Gangarao Davuluri, Jenny G. Parvani, et al.. (2013). Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells. Breast Cancer Research and Treatment. 142(2). 341–353. 52 indexed citations
10.
Wendt, Michael K., Barbara J. Schiemann, Jenny G. Parvani, et al.. (2012). TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer. Oncogene. 32(16). 2005–2015. 62 indexed citations
11.
Wendt, Michael K., Molly A. Taylor, Barbara J. Schiemann, & William P. Schiemann. (2011). Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Molecular Biology of the Cell. 22(14). 2423–2435. 144 indexed citations
12.
Patrick, Aaron, Barbara J. Schiemann, Kui Yang, Rui Zhao, & Heide L. Ford. (2009). Biochemical and Functional Characterization of Six SIX1 Branchio-oto-renal Syndrome Mutations. Journal of Biological Chemistry. 284(31). 20781–20790. 35 indexed citations
14.
Emerson, David L., Carol Bell, Mark Jones, Barbara J. Schiemann, & Gilles Tapolsky. (2006). Oral bioavailabity and antitumor activity of TPI 287 a new taxane analog with greater activity than paclitaxel against tumor cells with demonstrated mutant tubulin. 66. 116–117. 5 indexed citations
15.
16.
Schiemann, Barbara J., Jason R. Neil, & William P. Schiemann. (2003). SPARC Inhibits Epithelial Cell Proliferation in Part through Stimulation of the Transforming Growth Factor-β–Signaling System. Molecular Biology of the Cell. 14(10). 3977–3988. 127 indexed citations
17.
Schiemann, Barbara J., Jennifer L. Gommerman, Kalpit A. Vora, et al.. (2001). An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway. Science. 293(5537). 2111–2114. 877 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026